Skip to main content
. 2024 Apr 20;47(7):699–710. doi: 10.1007/s40264-024-01425-5

Table 8.

Elevations in on-treatment ALT and BILI values in reference to the individual subject’s pretreatment values (BLN) by treatment arm

Analyte Placebo
n = 249
Study drug
n = 748
RR
(95% CI)
% change
ALT > 1×BLN 220 (88.4) 51 (6.8) 0.08 (0.06–0.10) −81.6
BILI > 1×BLN 218 (87.6) 732 (97.9) 1.10 (1.00–1.10) 10.3

ALT alanine aminotransferase, BILI total bilirubin, BLN baseline liver test value, CI confidence interval, RR risk ratio